 Connection
Anne Fuhlbrigge to Adrenal Cortex Hormones
This is a "connection" page, showing publications Anne Fuhlbrigge has written about Adrenal Cortex Hormones.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
3.227 |
|
|
|
-
Fuhlbrigge AL, Sharma S. Oral Corticosteroid Use in Asthma: A Wolf in Sheep's Clothing. J Allergy Clin Immunol Pract. 2021 01; 9(1):347-348.
Score: 0.574
-
Wu AC, Gay C, Rett MD, Stout N, Weiss ST, Fuhlbrigge AL. Pharmacogenomic test that predicts response to inhaled corticosteroids in adults with asthma likely to be cost-saving. Pharmacogenomics. 2015; 16(6):591-600.
Score: 0.386
-
Fuhlbrigge AL, Kelly HW. Inhaled corticosteroids in children: effects on bone mineral density and growth. Lancet Respir Med. 2014 Jun; 2(6):487-96.
Score: 0.360
-
Fuhlbrigge AL, Lemanske RF, Rasouliyan L, Sorkness CA, Fish JE. Practice patterns for oral corticosteroid burst therapy in the outpatient management of acute asthma exacerbations. Allergy Asthma Proc. 2012 Jan-Feb; 33(1):82-9.
Score: 0.307
-
Gold DR, Fuhlbrigge AL. Inhaled corticosteroids for young children with wheezing. N Engl J Med. 2006 May 11; 354(19):2058-60.
Score: 0.208
-
Fuhlbrigge AL, Bae SJ, Weiss ST, Kuntz KM, Paltiel AD. Cost-effectiveness of inhaled steroids in asthma: impact of effect on bone mineral density. J Allergy Clin Immunol. 2006 Feb; 117(2):359-66.
Score: 0.204
-
Keller T, Spece LJ, Donovan LM, Udris E, Coggeshall SS, Griffith M, Bryant AD, Casaburi R, Cooper JA, Criner GJ, Diaz PT, Fuhlbrigge AL, Gay SE, Kanner RE, Martinez FJ, Panos RJ, Shade D, Sternberg A, Stibolt T, Stoller JK, Tonascia J, Wise R, Yusen RD, Au DH, Feemster LC. Association of Guideline-Recommended COPD Inhaler Regimens With Mortality, Respiratory Exacerbations, and Quality of Life: A Secondary Analysis of the Long-Term Oxygen Treatment Trial. Chest. 2020 08; 158(2):529-538.
Score: 0.136
-
Cardet JC, Busse PJ, Carroll JK, Casale TB, Coyne-Beasley T, Dixon-Williams S, Fagan M, Forth VE, Fuhlbrigge AL, Hernandez ML, Kaelber D, Kaplan B, Lorenzi M, Madison S, Maher NE, Majewski K, Manning B, McKee MD, Nazario S, Pace WD, Pencina MJ, Rand CS, Rodriguez-Louis J, She L, Shields J, Teng JE, Wechsler ME, Wisnivesky JP, Yawn BP, Israel E. Adherence to adding inhaled corticosteroids to rescue therapy in a pragmatic trial with adults with asthma: A pilot study. Ann Allergy Asthma Immunol. 2020 05; 124(5):487-493.e1.
Score: 0.134
-
Grossman NL, Doros GD, Fandino N, Fuhlbrigge AL, Pace WD, Wechsler ME, Yawn BP, Israel E. Susceptibility to exacerbations in Black adults with asthma. J Asthma. 2019 Jul; 56(7):704-710.
Score: 0.123
-
Lane SJ, Petersen H, Seltzer JM, Blanchette CM, Navaratnam P, Allen-Ramey F, Fuhlbrigge A. Moderate symptom-based exacerbations as predictors of severe claims-based exacerbations in asthma. J Asthma. 2013 Aug; 50(6):642-8.
Score: 0.084
-
Wu AC, Gregory M, Kymes S, Lambert D, Edler J, Stwalley D, Fuhlbrigge AL. Modeling asthma exacerbations through lung function in children. J Allergy Clin Immunol. 2012 Nov; 130(5):1065-70.
Score: 0.081
-
Fuhlbrigge A, Peden D, Apter AJ, Boushey HA, Camargo CA, Gern J, Heymann PW, Martinez FD, Mauger D, Teague WG, Blaisdell C. Asthma outcomes: exacerbations. J Allergy Clin Immunol. 2012 Mar; 129(3 Suppl):S34-48.
Score: 0.078
-
Cooke CE, Sidel M, Belletti DA, Fuhlbrigge AL. Review: clinical inertia in the management of chronic obstructive pulmonary disease. COPD. 2012 Feb; 9(1):73-80.
Score: 0.077
-
Cohen RT, Raby BA, Van Steen K, Fuhlbrigge AL, Celed?n JC, Rosner BA, Strunk RC, Zeiger RS, Weiss ST. In utero smoke exposure and impaired response to inhaled corticosteroids in children with asthma. J Allergy Clin Immunol. 2010 Sep; 126(3):491-7.
Score: 0.070
-
Sawicki GS, Strunk RC, Schuemann B, Annett R, Weiss S, Fuhlbrigge AL. Patterns of inhaled corticosteroid use and asthma control in the Childhood Asthma Management Program Continuation Study. Ann Allergy Asthma Immunol. 2010 Jan; 104(1):30-5.
Score: 0.067
-
Rogers AJ, Tantisira KG, Fuhlbrigge AL, Litonjua AA, Lasky-Su JA, Szefler SJ, Strunk RC, Zeiger RS, Weiss ST. Predictors of poor response during asthma therapy differ with definition of outcome. Pharmacogenomics. 2009 Aug; 10(8):1231-42.
Score: 0.065
-
Ugalde IC, Ratigan A, Merriman C, Cui J, Ericson B, Busse P, Carroll JK, Casale T, Celed?n JC, Coyne-Beasley T, Fagan M, Fuhlbrigge AL, Villarreal GG, Hernandez PA, Jariwala S, Kruse J, Maher NE, Manning B, Mosnaim G, Nazario S, Pace WD, Phipatanakul W, Pinto-Plata V, Riley I, Rodriguez-Louis J, Salciccioli J, Shenoy K, Shields JB, Tarabichi Y, Sosa BT, Wechsler ME, Wisnivesky J, Yawn B, Israel E, Cardet JC. Preference for and impact of telehealth vs in-person asthma visits among Black and Latinx adults. Ann Allergy Asthma Immunol. 2023 11; 131(5):614-627.e2.
Score: 0.043
-
Cardet JC, Chang KL, Rooks BJ, Carroll JK, Celed?n JC, Coyne-Beasley T, Cui J, Ericson B, Forth VE, Fagan M, Fuhlbrigge AL, Hernandez PA, Kruse J, Louisias M, Maher NE, Manning B, Pace WD, Phipatanakul W, Rodriguez-Louis J, Shields JB, Israel E, Wisnivesky JP. Socioeconomic status associates with worse asthma morbidity among Black and Latinx adults. J Allergy Clin Immunol. 2022 10; 150(4):841-849.e4.
Score: 0.039
-
Adams RJ, Fuhlbrigge AL, Finkelstein JA, Weiss ST. Intranasal steroids and the risk of emergency department visits for asthma. J Allergy Clin Immunol. 2002 Apr; 109(4):636-42.
Score: 0.039
-
Paltiel AD, Fuhlbrigge AL, Kitch BT, Liljas B, Weiss ST, Neumann PJ, Kuntz KM. Cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: results from the asthma policy model. J Allergy Clin Immunol. 2001 Jul; 108(1):39-46.
Score: 0.037
-
Israel E, Cardet JC, Carroll JK, Fuhlbrigge AL, Pace WD, Maher NE, She L, Rockhold FW, Fagan M, Forth VE, Hernandez PA, Manning BK, Rodriguez-Louis J, Shields JB, Coyne-Beasley T, Kaplan BM, Rand CS, Morales-Cosme W, Wechsler ME, Wisnivesky JP, White M, Yawn BP, McKee MD, Busse PJ, Kaelber DC, Nazario S, Hernandez ML, Apter AJ, Chang KL, Pinto-Plata V, Stranges PM, Hurley LP, Trevor J, Casale TB, Chupp G, Riley IL, Shenoy K, Pasarica M, Calderon-Candelario RA, Tapp H, Baydur A. A randomized, open-label, pragmatic study to assess reliever-triggered inhaled corticosteroid in African American/Black and Hispanic/Latinx adults with asthma: Design and methods of the PREPARE trial. Contemp Clin Trials. 2021 02; 101:106246.
Score: 0.036
-
Diette GB, Fuhlbrigge AL, Allen-Ramey F, Hopper A, Sajjan SG, Markson LE. Asthma Severity in patients initiating controller monotherapy versus combination therapy. J Asthma. 2011 Apr; 48(3):304-10.
Score: 0.018
-
Brehm JM, Schuemann B, Fuhlbrigge AL, Hollis BW, Strunk RC, Zeiger RS, Weiss ST, Litonjua AA. Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. J Allergy Clin Immunol. 2010 Jul; 126(1):52-8.e5.
Score: 0.017
-
Bae SJ, Paltiel AD, Fuhlbrigge AL, Weiss ST, Kuntz KM. Modeling the potential impact of a prescription drug copayment increase on the adult asthmatic medicaid population. Value Health. 2008 Jan-Feb; 11(1):110-8.
Score: 0.015
-
Tantisira KG, Silverman ES, Mariani TJ, Xu J, Richter BG, Klanderman BJ, Litonjua AA, Lazarus R, Rosenwasser LJ, Fuhlbrigge AL, Weiss ST. FCER2: a pharmacogenetic basis for severe exacerbations in children with asthma. J Allergy Clin Immunol. 2007 Dec; 120(6):1285-91.
Score: 0.014
-
Finkelstein JA, Lozano P, Fuhlbrigge AL, Carey VJ, Inui TS, Soumerai SB, Sullivan SD, Wagner EH, Weiss ST, Weiss KB. Practice-level effects of interventions to improve asthma care in primary care settings: the Pediatric Asthma Care Patient Outcomes Research Team. Health Serv Res. 2005 Dec; 40(6 Pt 1):1737-57.
Score: 0.013
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|